- CA$4.13m
- CA$4.31m
- 26
- 52
- 19
- 24
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.53 | 0.592 | 1.72 | 4.82 | 3.71 |
Operating Profit | -5.53 | -0.592 | -1.72 | -4.82 | -3.71 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.5 | -0.592 | -1.72 | -4.82 | -3.71 |
Net Income After Taxes | -5.5 | -0.592 | -1.72 | -4.82 | -3.71 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.5 | -0.592 | -1.72 | -4.82 | -3.71 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.5 | -0.592 | -1.72 | -4.82 | -3.71 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.535 | -0.075 | -0.198 | -0.32 | -0.149 |